March 19 (Reuters) - TG Therapeutics Inc TGTX.O:
TG THERAPEUTICS SECURES AN ADDITIONAL $500 MILLION IN NON-DILUTIVE CAPITAL FROM BLUE OWL AND EXPANDS SHARE REPURCHASE PROGRAM TO $300 MILLION
TG THERAPEUTICS INC - ENTERS FIVE-YEAR $750 MILLION CREDIT FACILITY WITH BLUE OWL CAPITAL
TG THERAPEUTICS INC - INCREASES SHARE REPURCHASE PROGRAM TO $300 MILLION